These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738 [TBL] [Abstract][Full Text] [Related]
8. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173 [TBL] [Abstract][Full Text] [Related]
9. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Baeres M; Herkel J; Czaja AJ; Wies I; Kanzler S; Cancado EL; Porta G; Nishioka M; Simon T; Daehnrich C; Schlumberger W; Galle PR; Lohse AW Gut; 2002 Aug; 51(2):259-64. PubMed ID: 12117891 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study. Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. Kanzler S; Weidemann C; Gerken G; Löhr HF; Galle PR; Meyer zum Büschenfelde KH; Lohse AW J Hepatol; 1999 Oct; 31(4):635-40. PubMed ID: 10551386 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and HLA genotypes in Chinese patients with anti-SLA/LP-positive autoimmune hepatitis. Zhang HP; Liu YM; Li Z; Ma YX; Li LJ; Zhao DT; Lou JL; Gao ZH; Yan HP Ann Transl Med; 2021 Jan; 9(2):153. PubMed ID: 33569455 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381 [TBL] [Abstract][Full Text] [Related]
14. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis]. Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317 [TBL] [Abstract][Full Text] [Related]
15. Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Mix H; Weiler-Normann C; Thimme R; Ahlenstiel G; Shin EC; Herkel J; David CS; Lohse AW; Rehermann B Gastroenterology; 2008 Dec; 135(6):2107-18. PubMed ID: 18773898 [TBL] [Abstract][Full Text] [Related]
16. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients]. Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis. Chen ZX; Shao JG; Shen Y; Zhang J; Hua Y; Wang LJ; Qin G Medicine (Baltimore); 2015 Jun; 94(23):e953. PubMed ID: 26061326 [TBL] [Abstract][Full Text] [Related]
19. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas. Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415 [TBL] [Abstract][Full Text] [Related]